|
1. Khanahmadi M, Farhud D, Malmir M. Genetic of alzheimer's disease: a narrative review article. Iran J Public Health. 2015; 44(7): 892-901. 2. Kroker KS, Rast G, Giovannini R, Marti A, Dorner-Ciossek C, Rosenbrock H. Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP. Neuropharmacology. 2012 Apr;62(5-6):1964-74. doi:10.1016/j.neuropharm.2011.12.021 3. D'Amelio M, Rossini PM. Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: from animal models to human findings. Prog Neurobiol. 2012 Oct;99(1):42-60. doi:10.1016/j.pneurobio.2012.07.001 4. Dumas JA, Newhouse PA. The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav. 2011 Aug; 99(2):254-61. doi:10.1016/j.pbb.2011.02.022 5. Easton A, Sankaranarayanan S, Tanghe A, Terwel D, Lin AX, Hoque N, et al. Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's disease. Psychopharmacology (Berl). 2013 Nov;230(2):279-89. doi:10.1007/s00213-013-3152-3 6. Raghanti MA, Simic G, Watson S, Stimpson CD, Hof PR, Sherwood CC. Comparative analysis of the nucleus basalis of Meynert among primates. Neuroscience. 2011 Jun; 184:1-15. doi:10.1016/j.neuroscience.2011.04.008 7. Nyakas C, Granic I, Halmy LG, Banerjee P, Luiten PG. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-42 with memantine. Behav Brain Res. 2011 Aug; 221(2):594-603. doi:10.1016/j.bbr.2010.05.033 8. Paleja M, Girard TA, Herdman KA, Christensen BK. Two distinct neural networks functionally connected to the human hippocampus during pattern separation tasks. Brain Cogn. 2014 Nov; 92C:101-111. doi:10.1016/j.bandc.2014.10.009 9. Yamaguchi Y, Higashi M, Matsuno T, Kawashima S. Ameliorative effects of azaindolizinone derivative ZSET845 on scopolamine-induced deficits in passive avoidance and radial-arm maze learning in the rat. Jpn J Pharmacol. 2001 Nov; 87(3):240-4. 10. Gratwicke J, Kahan J, Zrinzo L, Hariz M, Limousin P, Foltynie T, et al. The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia? Neurosci Biobehav Rev. 2013 Dec; 37(10 Pt 2): 2676-88. doi:10.1016/j.neubiorev.2013.09.003 11. Saxena G, Patro IK, Nath C. ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor. Behav Brain Res. 2011 Oct; 224(1):50-7. doi:10.1016/j.bbr.2011.04.039 12. Shahraki A, Ghahghaei A, Zakeri Z. [Glutamate transporters and excitotoxicity in nervous system]. J Gorgan Univ Med Sci. 2011; 13(3): 1-15. [Article in Persian] 13. Akaike A, Takada-Takatori Y, Kume T, Izumi Y. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection. J Mol Neurosci. 2010 Jan; 40(1-2): 211-6. doi:10.1007/s12031-009-9236-1 14. Creed MC, Milgram NW. Amyloid-modifying therapies for alzheimer's disease: Therapeutic progress and its implication. Age (Dordr). 2010 Sep; 32(3): 365-84. doi:10.1007/s11357-010-9142-z 15. Kapai NA, Bukanova JV, Solntseva EI, Skrebitsky VG. Donepezil in a narrow concentration range arguments control and impaired by beta-amyloid peptide hippocampal LTP in NMDA-independent manner. Cell Mol Neurobiol. 2012; 32: 219-26. 16. Cutuli D, De Bartolo P, Caporali P, Tartaglione AM, Oddi D, D'Amato FR, et al. Neuroprotective effects of donepezil against cholinergic depletion. Alzheimers Res Ther. 2013 Oct; 5(5):50. doi:10.1186/alzrt215 17. Freret T, Bouet V, Quiedeville A, Nee G, Dallemagne P, Rochais C, Boulouard M. Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT(4) receptor activation (RS67333) on object recognition in mice. Behav Brain Res. 2012 Apr; 230(1): 304-8. doi:10.1016/j.bbr.2012.02.012 18. Shen H, Kihara T, Hongo H, Wu X, Kem WR, Shimohama S, et al. Neuroprotection by donepezil against glutamate exitotoxicity involves stimulation of alpha7 nicotonic receptors and internalization of NMDA receptor. British J Pharmacol. 2010; 161(1): 127-39. doi:10.1111/j.1476-5381.2010.00894.x 19. Liu P, Bilkey DK. The effects of NMDA lesions centered on the postrhinal cortex on spatial memory tasks in the rat. Behav Neurosci. 2002 Oct; 116(5):860-73. 20. Davis CP, Franklin LM, Johnson GS, Schrott LM. Prenatal oxycodone exposure impairs spatial learning and/or memory in rats. Behav Brain Res. 2010 Sep; 212(1):27-34. doi:10.1016/j.bbr.2010.03.022 21. Lindner MD, Hogan JB, Hodges DB Jr, Orie AF, Chen P, Corsa JA, et al. Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping. Psychopharmacology (Berl). 2006 Nov;188(4):629-40. doi:10.1007/s00213-006-0556-3 22. Zahedi M, Hojjati MR, Fathpour H, Rabiei Z, Alibabaei Z, Basim A. Effect of Rheum Ribes Hydro-Alcoholic Extract on Memory Impairments in Rat Model of Alzheimer's Disease. Iran J Pharm Res. 2015 Fall; 14(4):1197-206. 23. Rabiei Z, Rafieian-Kopaei M, Heidarian E, Saghaei E, Mokhtari S. Effects of Zizyphus jujube extract on memory and learning impairment induced by bilateral electric lesions of the nucleus Basalis of Meynert in rat. Neurochem Res. 2014 Feb; 39(2):353-60. doi:10.1007/s11064-013-1232-8 24. Mesulam MM. Some cholinergic themes related to Alzheimer's disease: synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity. J Physiol Paris. 1998 Jun-Aug;92(3-4):293-8. 25. Takada-Takatori Y, Kume T, Izumi Y, Ohgi Y, Niidome T, Fujii T, et al. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation. Biol Pharm Bull. 2009 Mar;32(3):318-24. 26. Xu AJ, Chen Z, Yanai K, Huang YW, Wei EQ. Effect of 3-[1-(phenylmethyl)-4-piperidinyl]-1- (2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)- 1- propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitive impairment induced by chronic cerebral hypoperfusion in rats. Neurosci Lett. 2002 Oct; 331(1):33-6. 27. Spowart-Manning L, van der Staay FJ. The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse. Behav Brain Res. 2004 May; 151(1-2):37-46. 28. Sharma B, Singh N, Singh M. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil. J Psychopharmacol. 2008 Mar; 22(2):162-71. doi:10.1177/0269881107081553
|
